Get notified when ACMR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsACM Research's Shanghai unit seeks Hong Kong listing for up to 7% of shares
Filed May 29, 2026 · Period ending May 26, 2026 · ~1 min read
Key Changes
-
high
ACM Shanghai board approved plan to issue H shares representing up to 7% of total capital on Hong Kong Stock Exchange Main Board, with potential 15% over-allotment option. Still requires shareholder vote and regulatory approvals from Chinese and Hong Kong authorities.
Item 8.01 verify on EDGAR → -
medium
Proceeds will fund product development, R&D capabilities, global market expansion, working capital, and bank loan repayment. Indicates company seeking growth capital and balance sheet strengthening.
Item 8.01 verify on EDGAR → -
medium
Listing contingent on approvals from China Securities Regulatory Commission, Hong Kong Stock Exchange, and Hong Kong Securities and Futures Commission. Board resolution valid for 24 months from shareholder approval date.
Item 8.01 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade ACMR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 29, 2026 · How we verify